logo

For the Inventor, By the Inventor

Wokingham, United Kingdom

John F White

USPTO Granted Patents = 12

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 98(Granted Patents)


Location History:

  • Woosehill, GB (1993)
  • Wokingham, GB (1980 - 1996)

Company Filing History:

goldMedal12 out of 299 
 
John Wyeth Brother, Limited
 patents

Years Active: 1980-1996

Loading Chart...
12 patents (USPTO):Explore Patents
1. 5538956 - Amine derivatives containing a phosphonic acid moiety (1996-07-23),
2. 5527955 - Method of treating depression and tri-substituted amines therefor (1996-06-18),
3. 5422355 - Composition for treating depression with (N-heteroaryl)alkylamines (1995-06-06),
4. 5321047 - Method and amines used therein (1994-06-14),
5. 5260331 - Composition for treating depression with (S- or O-heteroaryl)alkyl amines (1993-11-09),
6. 5210088 - Method of treatment and heterocyclic compounds used therein (1993-05-11),
7. 5118690 - Pharmaceutical tetrahydroisoquinolines (1992-06-02),
8. 5086073 - Composition for treating depression with aralkyl amines (1992-02-04),
9. 4550114 - Benzoquinolizines as .alpha..sub.2 -adrenoceptor antagonists (1985-10-29),
10. 4481200 - .alpha..sub.2 -Adrenoceptor antagonistic benzoquinolizines (1984-11-06),
11. 4328232 - Benzoquinolizines, anti-secretory compositions containing them, and (1982-05-04),
12. 4235910 - Benzoquinolizines having blood pressure lowering activity, and in some (1980-11-25),

Title: John F. White: Innovator in Pharmaceutical Patents

Introduction

John F. White is a notable inventor based in Wokingham, GB, known for his valuable contributions to the field of pharmaceuticals. With a portfolio of 12 patents, White has focused on advancing treatments related to mental health and neurodegenerative conditions. His innovative work has garnered attention for its potential impact on therapeutic methods.

Latest Patents

Among White's latest patents is a groundbreaking invention concerning amine derivatives containing a phosphonic acid moiety. This particular patent details a method for treating depression and senile dementia using compounds that selectively act as agonists of gamma aminobutyric acid (GABA) at GABA autoreceptors. Importantly, the invention stipulates that the compounds referenced are not fengabine or progabide, thus offering novel pathways for treatment.

Career Highlights

John F. White is associated with John Wyeth & Brother Limited, a reputable company in the pharmaceutical industry. His career has been marked by his commitment to developing new therapies that address serious mental health and cognitive challenges. His extensive research and innovative thinking have established him as an authority in his field.

Collaborations

Throughout his career, White has collaborated with notable individuals, including his colleagues Michael C. Minchin and Christine Ennis. These collaborations have fostered a conducive environment for innovation, contributing to the successful development of new treatments in the pharmaceutical sector.

Conclusion

John F. White stands out as an instrumental figure in the realm of pharmaceutical inventions. With his impressive number of patents and dedication to addressing crucial health issues, he continues to influence the future of medical treatments. His work not only reflects his expertise but also his commitment to improving the lives of individuals facing mental health and cognitive challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…